Literature DB >> 11966761

Adhesion to fibronectin via alpha4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas/Apo-1 receptors.

M Garcia-Gila1, E M Lopez-Martin, A Garcia-Pardo.   

Abstract

Apoptosis is a regulated event crucial to the development and proliferation of normal and malignant B cells. We have studied the role of signals delivered via alpha4 integrin on apoptosis triggered by three different pathways on these cells. For apoptosis induced by serum deprivation, culturing B cells on the recombinant fibronectin fragment H89, a known ligand for alpha4beta1 integrin, resulted in statistically significant (P < 0.005) higher viability values (68%, 65% and 67%) for Ramos, Nalm-6 and EHEB cells, respectively, than culturing cells on poly lysine (42%, 42% and 48%). An antialpha4 MoAb reverted the protecting effect, thus confirming that it was due specifically to alpha4 engagement. Similarly, cells cultured on FN-III4-5, a recently identified fibronectin region which binds activated alpha4 integrin, also showed statistically significant higher viability than poly lysine cultures. Alpha4 engagement however, did not prevent apoptosis induced on Ramos cells via surface IgM. Adhesion of IM-9 cells, a myeloma cell line carrying functional Fas receptors, to the H89 fragment neither increased cell viability upon triggering apoptosis via Fas when compared to poly lysine. These results indicate that alpha4 signalling may overcome B cell apoptosis induced by the lack of growth factors but does not seem to affect the IgM or Fas apoptotic pathways, thus suggesting different intracellular mechanisms for these processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966761      PMCID: PMC1906315          DOI: 10.1046/j.1365-2249.2002.01787.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Inhibition of B cell receptor-mediated apoptosis by IFN.

Authors:  L Su; M David
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

Review 2.  B-cell receptor and Fas-mediated signals for life and death.

Authors:  G B Carey; D Donjerković; C M Mueller; S Liu; J A Hinshaw; L Tonnetti; W Davidson; D W Scott
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

3.  Human B lymphocytes define an alternative mechanism of adhesion to fibronectin. The interaction of the alpha 4 beta 1 integrin with the LHGPEILDVPST sequence of the type III connecting segment is sufficient to promote cell attachment.

Authors:  A Garcia-Pardo; E A Wayner; W G Carter; O C Ferreira
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

4.  TNF-alpha inhibits anti-IgM-mediated apoptosis in Ramos cells.

Authors:  E Park; C I Kalunta; T T Nguyen; C L Wang; F S Chen; C K Lin; J S Kaptein; P M Lad
Journal:  Exp Cell Res       Date:  1996-07-10       Impact factor: 3.905

5.  A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.

Authors:  S M Lens; K Tesselaar; B F den Drijver; M H van Oers; R A van Lier
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

6.  Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells.

Authors:  G Koopman; R M Keehnen; E Lindhout; W Newman; Y Shimizu; G A van Seventer; C de Groot; S T Pals
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

7.  Integrin alpha 4 beta 1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin.

Authors:  A P Mould; J A Askari; S E Craig; A N Garratt; J Clements; M J Humphries
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

8.  Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking.

Authors:  S Sumimoto; T Heike; S Kanazashi; N Shintaku; E Y Jung; D Hata; K Katamura; M Mayumi
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

9.  Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin.

Authors:  E A Wayner; A Garcia-Pardo; M J Humphries; J A McDonald; W G Carter
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

10.  Fas ligation induces apoptosis of CD40-activated human B lymphocytes.

Authors:  P Garrone; E M Neidhardt; E Garcia; L Galibert; C van Kooten; J Banchereau
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  5 in total

1.  Tumorigenic potential and disease manifestations of malignant B-cell variants differing in their fibronectin adhesiveness.

Authors:  Liat Nadav; Vyacheslav Kalchenko; Meir Max Barak; Elizabeth Naparstek; Benjamin Geiger; Ben-Zion Katz
Journal:  Exp Hematol       Date:  2008-08-09       Impact factor: 3.084

Review 2.  Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches.

Authors:  Marina Konopleva; Yoko Tabe; Zhihong Zeng; Michael Andreeff
Journal:  Drug Resist Updat       Date:  2009-07-25       Impact factor: 18.500

Review 3.  Advances in understanding the leukaemia microenvironment.

Authors:  Yoko Tabe; Marina Konopleva
Journal:  Br J Haematol       Date:  2014-01-09       Impact factor: 6.998

4.  Anchorage on fibronectin via VLA-5 (alpha5beta1 integrin) protects rheumatoid synovial cells from Fas-induced apoptosis.

Authors:  A Kitagawa; Y Miura; R Saura; M Mitani; H Ishikawa; A Hashiramoto; S Yoshiya; S Shiozawa; M Kurosaka
Journal:  Ann Rheum Dis       Date:  2005-10-25       Impact factor: 19.103

5.  Anti-leukemic response of a NSAID, tolfenamic acid.

Authors:  Robert M Sutphin; Sarah F Connelly; Chris M Lee; Umesh T Sankpal; Don Eslin; Moeez Khan; Hima Pius; Riyaz Basha
Journal:  Target Oncol       Date:  2013-04-23       Impact factor: 4.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.